表紙
市場調査レポート

中国の血液疾患治療薬市場

Blood Disease Drugs Markets in China

発行 Asia Market Information & Development 商品コード 91227
出版日 ページ情報 英文 290 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
中国の血液疾患治療薬市場 Blood Disease Drugs Markets in China
出版日: 2016年05月01日 ページ情報: 英文 290 Pages
概要

当レポートでは、中国の経済動向、血液疾患治療薬市場の投資環境、産業の発展、需要および供給、産業構造、市場チャネルおよび主要企業などについて詳細に調査し、実績、長期予測を提示しています。

第1章 イントロダクション

  • 本調査書の範囲と方法論
  • エグゼクティブサマリー

第2章 ビジネス環境

  • 経済展望
    • 主な経済指標
    • 工業生産量
    • 人口および労働力
    • 海外からの投資
    • 海外貿易
  • 金融および税金の規制
    • 銀行制度および規制
    • 外国為替
    • 税金、関税および税関

第3章 血液疾患治療薬産業の評価

  • 産業構造
  • 市場規模
  • 市場成長促進要因
  • 販売量
  • 主要メーカーの設備拠点および販売量
  • 主なメーカーの市場シェア
  • 労働コスト
  • 潜在性のある参入企業
  • 主な流通業者
  • 主な海外からの投資
  • 技術開発

第4章 血液疾患治療薬の生産および需要

  • 概要
  • 地域別需要
  • 血液疾患治療薬の販売量
    • 貧血症
    • 好中球減少症および粒球減少症
    • 白血病
    • その他
  • 血液疾患治療薬の輸入
  • 価格動向

第5章 血液疾患治療薬市場の展望

  • 血液疾患治療薬市場の展望
  • 政府の規制
  • 健康保険産業の概要
  • 消費者支出動向
  • 人口動態
  • 医療産業の動向
  • 病院および病床
  • 医師および往診

第6章 マーケティング戦略

  • 中国市場参入の概要
    • 中国流通システム
    • 血液疾患治療薬の流通チャネル
    • 運輸および輸送インフラ
    • 通信
  • 中国市場参入
    • 対中国輸出
    • 間接輸出
    • 直接輸出
    • ライセンスおよび提携製造
    • 中国内の組み立て
    • 提携製造
    • 貿易許可
    • 投資
    • 資本提携
    • 合併企業
    • 完全外資企業

第7章 血液疾患治療薬メーカーのディレクトリー

  • メーカーのプロファイル
  • 流通業者および貿易会社
  • 研究機関および協会

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 805

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Blood Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Blood Disease Drugs by Region
  • Blood Disease Drugs Sales Volume
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Sales Volume
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Imports
  • Anemia Treatment Drugs
  • Mecobalamin
  • Cobamamide
  • Ferrous Succinate
  • Leucogen
  • Neutropenia and Agranulocytosis Treatment Drugs Imports
  • VitamineB4
  • Batilol
  • Inosine
  • Deoxyribonucleotide
  • Adrenocortical Hormone
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • Leukemia Treatment Drugs Imports
  • Interferon
  • Imatinib
  • Rituximab
  • Pirarubicin
  • Hydroxycampothecin
  • Other Blood Disease Drugs Imports
  • Pricing Trends

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Blood Disease Drugs Market Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY

  • Blood Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume
  • Major Producer Facility Location
  • Major Blood Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Blood Disease Drugs Sales Volume
  • Blood Disease Drugs Major Producer and Their Market Share
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Anemia Treatment Drugs Major Producer and Their Market Share
  • Mecobalamin Major Producer and Their Market Share
  • Cobamamide Major Producer and Their Market Share
  • Ferrous Succinate Major Producer and Their Market Share
  • Leucogen Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Major Producer and Their Market Share
  • Batilol Major Producer and Their Market Share
  • Inosine Major Producer and Their Market Share
  • Deoxyribonucleotide Major Producer and Their Market Share
  • Adrenocortical Hormone Major Producer and Their Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
  • Leukemia Treatment Drugs Major Producer and Their Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Major Producers and Their Market Share
  • Imatinib Mesylate Major Producer and Their Market Share
  • Rituximab Major Producer and Their Market Share
  • Pirarubicin Major Producer and Their Market Share
  • Hydroxycampothecin Major Producer and Their Market Share
  • Blood Disease Drugs Import
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • Leukemia Treatment Drugs Import Volume by Drugs Classification

V. BLOOD DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

ULIST OF CHARTS

I. NTRODUCTION

  • Blood Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Blood Disease Drugs Sales Volume

IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND

  • Blood Disease Drugs Sales Volume
  • Worldwide Blood Disease Drugs Demand by region
  • Anemia Major Producer and Their Market Share
  • Anemia Treatment Drugs Sales Volume by Drugs Classification
  • Mecobalamin Sales Volume and Market Share
  • Cobamamide Sales Volume and Market Share
  • Ferrous Succinate Sales Volume and Market Share
  • Leucogen Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
  • VitamineB4 Sales Volume and Market Share
  • Batilol Sales Volume and Market Share
  • Inosine Sales Volume and Market Share
  • Deoxyribonucleotide Sales Volume and Market Share
  • Adrenocortical Hormone Sales Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume and Market Share
  • Leukemia Treatment Drugs Sales Volume by Drugs Classification
  • Interferon Sales Volume and Market Share
  • Imatinib Mesylate Sales Volume and Market Share
  • Rituximab Sales Volume and Market Share
  • Pirarubicin Sales Volume and Market Share
  • Hydroxycampothecin Sales Volume and Market Share
  • Other Blood Disease Drugs Sales volume and Market Share
  • Blood Disease Drugs Import Volume
  • Anemia Import Volume and Market Share
  • Anemia Treatment Drugs Import Volume by Drugs Classification
  • Mecobalamin Import Volume and Market Share
  • Cobamamide Import Volume and Market Share
  • Ferrous Succinate Import Volume and Market Share
  • Leucogen Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume and Market Share
  • Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
  • VitamineB4 Import Volume and Market Share
  • Batilol Import Volume and Market Share
  • Inosine Import Volume and Market Share
  • Deoxyribonucleotide Import Volume and Market Share
  • Adrenocortical Hormone Import Volume and Market Share
  • Granulocyte Colony-Stimulating Factor(G-CSF) Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume and Market Share
  • Leukemia Treatment Drugs Import Volume by Drugs Classification
  • Interferon Treatment Drugs Import Volume and Market Share
  • Imatinib Mesylate Treatment Drugs Import Volume and Market Share
  • Rituximab Treatment Drugs Import Volume and Market Share
  • Pirarubicin Treatment Drugs Import Volume and Market Share
  • Hydroxycampothecin Treatment Drugs Import Volume and Market Share
  • Other Blood Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top